From Big Pharma to the cannabis industry: Q&A with PharmaCann’s Chris Diorio

By Omar Sacirbey

If marijuana business entrepreneurs are wondering whether pharmaceutical professionals might be interested in jumping over to cannabis, the answer is a resounding yes.

Take Chris Diorio, a 25-year pharma industry veteran who recently made such a move, becoming director of research and development for PharmaCann of New York.

PharmaCann has a cultivation and processing site and four vertically integrated dispensaries in New York, as well two grow sites in Illinois, where the company is headquartered.

Diorio’s path to PharmaCann started simply enough during a dinner with two former colleagues, one who previously worked with Diorio at Pfizer and the other a former retail pharmacist. Both were working at Bloomfield Industries, a PharmaCann competitor in the cannabis industry.

Intrigued by that initial conversation, Diorio did some investigating and learned the marijuana is attracting a growing number of pharma professionals. He also discovered cannabis companies that take the right approach likely will have no problem poaching talent from pharmaceutical companies.

Marijuana Business Daily spoke with Diorio about his move to work at a cannabis company, his perceptions of the MJ industry and what companies in this sector can do to lure a top pharma talent.

How did you end up at PharmaCann?

I just dropped (CEO) Teddy Scott a note and said, “Hey, if you’re around, I’d like to chat and see what’s going on over here.” And he said yes.

Fast-forward: We had dinner and I wanted to see what they were really doing and how they were different than what I envisioned a cannabis company would be. It went along with a similar vision to what I shared in the pharmaceutical industry, bringing something that’s beneficial for patients in a whole new light.

How did the company address any doubts you had about entering this industry after coming from Big Pharma?

They said that basically everyone else in the company had the same basic thoughts and questions. They also said to consider what is the upside and the positives of being in a new emerging industry.

Looking back five or six years ago, this wouldn’t have been something I would have even been considering, and many other people probably felt the same way.

But as mentalities have shifted and states have started legalizing, to get in on the ground floor with an emerging business was also very exciting and a good opportunity.

What’s been the biggest surprise so far?

When I look at the folks who are employed in the company and industry, and as I read articles and research online and get the lay of the land of who’s out there, there are a lot of other people like me who came out of the chemical industry, or engineers, many pharmacists. There are published Ph.D. scientists, people with drug-delivery patents.

It’s surprising but comforting to see that. And to see people who had a history in the pharmaceutical industry or the chemical industry, it’s helped solidify my decision. I became more sure of my move when I saw all that.

Are you hearing interest from former colleagues?

At least 15 former colleagues and acquaintances who are probably still working in some sort of mainstream pharma company as well as people on the sales and marketing side have contacted me. They want to know about the opportunities, the compensation, the benefits. They’re just bluntly asking if there are any job openings.

There are people inquiring with 25-plus years of experience and others who are industry newbies. I’ve gotten emails from friends of friends who are graduating from pharmacy school and asking to have conversations so they can learn about the industry.

People like that are always very intrigued and excited about a new industry.

What should a cannabis company do to successfully recruit from the pharma industry?

It depends on the company and the leadership that’s there.

If the proper leadership wasn’t there at PharmaCann, I never would have even had that first meeting. If it wasn’t what I felt comfortable with – if it was just somebody without any technology experience or any kind of scientific background or medical background – I would have been skeptical.

If a cannabis company is looking for a certain skillset or a certain person and they’re in (a desirable geographic area), and they have the right person making that contact, I think it would be pretty easy to get them.

This interview has been edited for length and clarity.

Omar Sacirbey can be reached at [email protected]

Daily News | Ancillary Marijuana Companies | Edibles/Infused Products | Featured | New York Medical Cannabis Business & Marijuana Legal News

 9 Comments

  1. Gary March 28, 2017
  2. California Kid March 28, 2017
  3. Gary March 28, 2017
  4. DabbyDooRight March 28, 2017
  5. Rick Fague March 28, 2017
    • A.Rasheed Shah March 29, 2017
  6. Andrew Norrman March 28, 2017
  7. Venkat March 29, 2017
    • A.Rasheed Shah March 29, 2017

Leave a Reply

Your email address will not be published. Required fields are marked *

Please note: Comments are moderated by our editors who do their best to approve comments ASAP. As Marijuana Business Daily is focused on business, we approve comments that are specifically relevant to industry professionals. General opinions and questions about cannabis may not be posted.